0
OnSite™ COVID-19 + Influenza A/B Ag Rapid Test kit, CE, 20 Tests
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
| Application | Diagnostic Testing | ||
| Storage Temperature | Room Temperature | ||
| Product Type | Test Kit | Forms | Kit with Various components |
| Product Brand | CTK Biotech | ||
| Product Grade | Medical grade | ||
The OnSite® COVID-19 + Influenza A/B Ag Rapid Test CE is a lateral flow immunoassay designed for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B antigens. Using a single swab specimen, it provides accurate and reliable results within 15 minutes, making it a practical diagnostic tool for healthcare facilities, clinics, and point-of-care testing.
By combining three tests in one device, it offers an efficient and convenient diagnostic solution, particularly useful during overlapping seasonal outbreaks of respiratory infections. The assay has demonstrated accurate detection within the first seven days of symptom onset, with validated performance against circulating SARS-CoV-2 variants and CDC-recommended influenza strains (2019–2022).
Key Features
- Triple Differentiation: Detects and distinguishes SARS-CoV-2, Influenza A, and Influenza B in one test.
- Efficient Testing: One swab specimen for three infections.
- Rapid Results: Results in 15 minutes.
- Accurate & Reliable: Validated against SARS-CoV-2 variants and CDC influenza strains (2019–2022).
- No Cross-Reactivity: Confirmed specificity against other respiratory viruses.
- Easy to Use: Pre-filled extraction tubes simplify workflow.
- Quality Control: External control swabs facilitate laboratory QC.
- Shelf Life: 24 months at 2–30 °C.
Kit Contents (20 Tests)
- Individually sealed foil pouches with cassette + desiccant
- Sealed pouch containing pre-filled extraction tubes
- Extraction tube nozzles
- Tube rack
- Individually packaged sterile swabs
- Instructions for Use
Applications
- Clinical Diagnosis: Rapid differential testing for patients presenting with respiratory symptoms.
- Hospitals & Clinics: Supports patient management during flu and COVID-19 seasons.
- Public Health Programs: Useful in outbreak surveillance and control.
- Point-of-Care Testing: Decentralized testing at screening centers, urgent care, and field sites.
The OnSite® COVID-19 + Influenza A/B Ag Rapid Test CE (R0188C) provides healthcare professionals with a fast, convenient, and reliable diagnostic tool for detecting and differentiating COVID-19, Influenza A, and Influenza B using a single swab. With results in 15 minutes, simplified procedures, and strong clinical performance, it is ideal for use in hospitals, clinics, and public health programs to support timely diagnosis and infection control.